Document Detail

Plasma and Brain Fatty Acid Profiles in Mild Cognitive Impairment and Alzheimer's Disease.
MedLine Citation:
PMID:  22269159     Owner:  NLM     Status:  Publisher    
Alzheimer's disease (AD) is generally associated with lower omega-3 fatty acid intake from fish but despite numerous studies, it is still unclear whether there are differences in omega-3 fatty acids in plasma or brain. In matched plasma and brain samples provided by the Memory and Aging Project, fatty acid profiles were quantified in several plasma lipid classes and in three brain cortical regions. Fatty acid data were expressed as % composition and as concentrations (mg/dL for plasma or mg/g for brain). Differences in plasma fatty acid profiles between AD, mild cognitive impairment (MCI), and those with no cognitive impairment (NCI) were most apparent in the plasma free fatty acids (lower oleic acid isomers and omega-6 fatty acids in AD) and phospholipids (lower omega-3 fatty acids in AD). In brain, % DHA was lower only in phosphatidylserine of mid-frontal cortex and superior temporal cortex in AD compared to NCI (-14% and -12%, respectively; both p < 0.05). The only significant correlation between plasma and brain fatty acids was between % DHA in plasma total lipids and % DHA in phosphatidylethanolamine of the angular gyrus, but only in the NCI group (+0.77, p < 0.05). We conclude that AD is associated with altered plasma status of both DHA and other fatty acids unrelated to DHA, and that the lipid class-dependent nature of these differences reflects a combination of differences in intake and metabolism.
Stephen C Cunnane; Julie A Schneider; Christine Tangney; Jennifer Tremblay-Mercier; Mélanie Fortier; David A Bennett; Martha Clare Morris
Related Documents :
18767799 - Chemistry of nitrated lipids: remarkable instability of 9-nitrolinoleic acid in neutral...
21553919 - Physical and water sorption properties of chemically modified pectin with an environmen...
7545559 - Altered lipid peroxidation/glutathione ratio in experimental extrahepatic cholestasis.
21218219 - Fabrication of a palladium nanoparticle/graphene nanosheet hybrid via sacrifice of a co...
8137899 - Effects of lipid peroxide on production of matrix metalloproteinase 1 (tissue collagena...
21243139 - A "by-productless" cellulose foaming agent for use in imidazolium ionic liquids.
15758219 - The pimfabcde operon from rhodopseudomonas palustris mediates dicarboxylic acid degrada...
1525949 - Antiinflammatory effect of tetramethylpyrazine and ferulic acid.
6206449 - Morphological study on glycosaminoglycans in the developing human vitreous.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-20
Journal Detail:
Title:  Journal of Alzheimer's disease : JAD     Volume:  -     ISSN:  1875-8908     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9814863     Medline TA:  J Alzheimers Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Research Center on Aging and Department of Medicine, Université de Sherbrooke, Sherbrooke, Québec, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adiponectin - An independent marker of coronary artery disease occurrence rather than a degree of it...
Next Document:  Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial.